Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kinsey

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
British Journal of Haematology|May 19, 2004
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J Harrison, Anthony V Moorman, Zoë J Broadfield, et al.
Scientific Reports|October 15, 2015
The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2AJayaram Vijayakrishnan, Marc Henrion, Anthony V Moorman, et al.
Blood|September 3, 2013
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGabriele Migliorini, Bettina Fiege, Fay J Hosking, et al.
Leukemia|October 4, 2016
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1J Vijayakrishnan, R Kumar, M Y R Henrion, et al.
Nature Genetics|May 11, 2010
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskAmy L Sherborne, Fay J Hosking, Rashmi B Prasad, et al.
Nature Communications|January 22, 2019
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemiaJayaram Vijayakrishnan, James Studd, Peter Broderick, et al.
Nature Communications|April 11, 2018
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemiaJayaram Vijayakrishnan, James Studd, Peter Broderick, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
British Journal of Haematology|May 19, 2004
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemiaChristine J Harrison, Anthony V Moorman, Zoë J Broadfield, et al.
Scientific Reports|October 15, 2015
The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2AJayaram Vijayakrishnan, Marc Henrion, Anthony V Moorman, et al.
Blood|September 3, 2013
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotypeGabriele Migliorini, Bettina Fiege, Fay J Hosking, et al.
Leukemia|October 4, 2016
A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1J Vijayakrishnan, R Kumar, M Y R Henrion, et al.
Nature Genetics|May 11, 2010
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskAmy L Sherborne, Fay J Hosking, Rashmi B Prasad, et al.
Nature Communications|January 22, 2019
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemiaJayaram Vijayakrishnan, James Studd, Peter Broderick, et al.
Nature Communications|April 11, 2018
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemiaJayaram Vijayakrishnan, James Studd, Peter Broderick, et al.
Pageof 10